Myrtaven, capsule

7680495060586 CH-49506 Kapseln

Associated product:

MYRTAVEN caps 60 pce
Myrtaven, capsule
Myrtaven, capsule
Myrtaven, capsule
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/12/2024
Patient information leaflet
Français
14/12/2024
Patient information leaflet
Italien
14/12/2024
Summary of Product Characteristics
Allemand
14/12/2024
Summary of Product Characteristics
Français
14/12/2024
Summary of Product Characteristics
Italien
14/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
58.0 MG Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 35.80
Specialties list
Yes
Generic
No
SL addition date: 15/03/1991

Authorization holder

IBSA Institut Biochimique SA

None Lugano

Authorization information

Swissmedic authorization number
49506
Drug name
Myrtaven, capsule
Galenic form
KAPS
ATC Code
C05CX
Authorization status
Z
Dispensing category
B
First authorization
05/09/1988
Authorization expiration date
31/12/9999
IT Number
02.08.1.
Domain
Human medicine

Package details

Description (FR)
MYRTAVEN caps 60 pce
Description (DE)
MYRTAVEN Kaps 60 Stk
Market launch
12/05/1997
Narcotic (BTM)
No

Other package sizes (3)

None
20 KAP
GTIN: None
Not in V1
None
60 KAP
GTIN: None
Not in V1
MYRTAVEN caps 20 pce
None None
GTIN: 7680495060319
Not in V1